Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a platform/version update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:20:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:36:02.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0 and no longer displays Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T20:04:00.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. This appears to be a minor page update.
    Difference
    0.1%
    Check dated 2026-03-07T13:07:52.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    - Updated page revision tag from v3.4.1 to v3.4.2; no impact on study content or user workflow.
    Difference
    0.1%
    Check dated 2026-02-14T01:44:33.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    An administrative version update is shown: 'Revision: v3.4.1' was added and 'Revision: v3.4.0' was removed. This appears to be metadata about the site and does not alter study data or page content.
    Difference
    0.1%
    Check dated 2026-02-06T14:23:24.000Z thumbnail image

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.